KR20230017206A - 결장 세포 증식성 장애를 식별하기 위한 rna 마커 및 방법 - Google Patents

결장 세포 증식성 장애를 식별하기 위한 rna 마커 및 방법 Download PDF

Info

Publication number
KR20230017206A
KR20230017206A KR1020227041793A KR20227041793A KR20230017206A KR 20230017206 A KR20230017206 A KR 20230017206A KR 1020227041793 A KR1020227041793 A KR 1020227041793A KR 20227041793 A KR20227041793 A KR 20227041793A KR 20230017206 A KR20230017206 A KR 20230017206A
Authority
KR
South Korea
Prior art keywords
mir
hsa
mirna
subject
cell proliferative
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
KR1020227041793A
Other languages
English (en)
Korean (ko)
Inventor
프랑세즈 암스트롱
시바니 마하잔
아담 하베이
아니샤 테와리
데이비드 웨인버그
제시 이튼
Original Assignee
프리놈 홀딩스, 인크.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 프리놈 홀딩스, 인크. filed Critical 프리놈 홀딩스, 인크.
Publication of KR20230017206A publication Critical patent/KR20230017206A/ko
Pending legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00—Libraries per se, e.g. arrays, mixtures
    • C40B40/04—Libraries containing only organic compounds
    • C40B40/06—Libraries containing nucleotides or polynucleotides, or derivatives thereof
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N20/00—Machine learning
    • G—PHYSICS
    • G06—COMPUTING OR CALCULATING; COUNTING
    • G06N—COMPUTING ARRANGEMENTS BASED ON SPECIFIC COMPUTATIONAL MODELS
    • G06N20/00—Machine learning
    • G06N20/20—Ensemble learning
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/20—Supervised data analysis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA

Landscapes

  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medical Informatics (AREA)
  • Data Mining & Analysis (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Zoology (AREA)
  • Theoretical Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Analytical Chemistry (AREA)
  • Software Systems (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Evolutionary Computation (AREA)
  • Artificial Intelligence (AREA)
  • Biochemistry (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Databases & Information Systems (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Bioethics (AREA)
  • Evolutionary Biology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Computing Systems (AREA)
  • General Physics & Mathematics (AREA)
  • Mathematical Physics (AREA)
KR1020227041793A 2020-04-29 2021-04-27 결장 세포 증식성 장애를 식별하기 위한 rna 마커 및 방법 Pending KR20230017206A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202063017552P 2020-04-29 2020-04-29
US63/017,552 2020-04-29
US202063024875P 2020-05-14 2020-05-14
US63/024,875 2020-05-14
PCT/US2021/029361 WO2021222220A2 (en) 2020-04-29 2021-04-27 Rna markers and methods for identifying colon cell proliferative disorders

Publications (1)

Publication Number Publication Date
KR20230017206A true KR20230017206A (ko) 2023-02-03

Family

ID=78332157

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020227041793A Pending KR20230017206A (ko) 2020-04-29 2021-04-27 결장 세포 증식성 장애를 식별하기 위한 rna 마커 및 방법

Country Status (8)

Country Link
US (1) US20230160019A1 (cg-RX-API-DMAC7.html)
EP (1) EP4143309A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023524016A (cg-RX-API-DMAC7.html)
KR (1) KR20230017206A (cg-RX-API-DMAC7.html)
CN (1) CN115812101A (cg-RX-API-DMAC7.html)
AU (1) AU2021263680A1 (cg-RX-API-DMAC7.html)
CA (1) CA3181389A1 (cg-RX-API-DMAC7.html)
WO (1) WO2021222220A2 (cg-RX-API-DMAC7.html)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019060716A1 (en) 2017-09-25 2019-03-28 Freenome Holdings, Inc. SAMPLE EXTRACTION METHODS AND SYSTEMS
KR20220015367A (ko) 2019-05-31 2022-02-08 프리놈 홀딩스, 인크. 메틸화된 핵산의 고심도 시퀀싱 방법 및 시스템
AU2021245992A1 (en) 2020-03-31 2022-11-10 Freenome Holdings, Inc. Methods and systems for detecting colorectal cancer via nucleic acid methylation analysis
CN116670510A (zh) 2020-10-05 2023-08-29 福瑞诺姆控股公司 用于结肠细胞增殖性病症的早期检测的标志物
CA3202255A1 (en) 2020-12-21 2022-06-30 Hayley WARSINSKE Markers for the early detection of colon cell proliferative disorders
JP2025517309A (ja) 2022-05-17 2025-06-05 ガーダント ヘルス， インコーポレイテッド 創薬可能な標的を特定するための方法およびがんを処置するための方法
WO2024009221A1 (en) * 2022-07-04 2024-01-11 Artificial Intelligence Expert Srl Method and system for multi-cancer management in subject
US11992318B2 (en) * 2022-07-13 2024-05-28 Celestin B. Bitjonck Diagnostic lab-on-a-chip device
CN118048450A (zh) * 2022-11-15 2024-05-17 杭州诺辉健康科技有限公司 使用miRNA亚型的家族占比检测癌症
US12587274B2 (en) 2023-03-28 2026-03-24 Quantum Generative Materials Llc Satellite optimization management system based on natural language input and artificial intelligence
US12368503B2 (en) 2023-12-27 2025-07-22 Quantum Generative Materials Llc Intent-based satellite transmit management based on preexisting historical location and machine learning
US12603701B2 (en) 2023-12-27 2026-04-14 Quantum Generative Materials Llc Distributed satellite constellation management and control system

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100010196A1 (en) * 1997-09-26 2010-01-14 Abt Holding Company Compositions and methods for non-targeted activation of endogenous genes
US20040018973A1 (en) * 2002-01-25 2004-01-29 University Of Pittsburgh Nuclear matrix protein alterations associated with colon cancer and colon metastasis to the liver, and uses thereof
NZ593226A (en) * 2006-01-11 2012-10-26 Genomic Health Inc Gene expression markers (efnb2) for colorectal cancer prognosis
EP2336353A1 (en) * 2009-12-17 2011-06-22 febit holding GmbH miRNA fingerprints in the diagnosis of diseases
JP2013526852A (ja) * 2010-04-06 2013-06-27 カリス ライフ サイエンシズ ルクセンブルク ホールディングス 疾患に対する循環バイオマーカー
WO2011128900A2 (en) * 2010-04-15 2011-10-20 Hadasit Medical Research Services And Development Ltd. Early detection and staging of colorectal cancer using a panel of micro rnas
US20120088687A1 (en) * 2010-10-08 2012-04-12 Baylor Research Institute MicroRNAs (miRNA) as Biomarkers for the Identification of Familial and Non-Familial Colorectal Cancer
EP2718463B1 (en) * 2011-06-08 2016-01-20 Comprehensive Biomarker Center GmbH Complex sets of mirnas as non-invasive biomarkers for dilated cardiomyopathy
US20160076098A1 (en) * 2013-04-12 2016-03-17 Drexel University Methods of diagnosing and treating chronic pain
EP3256607B1 (en) * 2015-02-13 2021-01-20 Patel, Abhijit Ajit Methods for highly parallel and accurate detection of nucleic acids
US10577645B2 (en) * 2016-03-18 2020-03-03 Norgen Biotek Corp. Methods and kits for improving global gene expression analysis of human blood, plasma and/or serum derived RNA
ES3002715T3 (en) * 2016-04-14 2025-03-07 Guardant Health Inc Methods for early detection of cancer
EP3571315B1 (en) * 2017-01-23 2025-01-08 Gatehouse Bio, Inc. Methods for identifying and using small rna predictors
AU2018243360B2 (en) * 2017-03-29 2023-10-26 Cornell University Devices, processes, and systems for determination of nucleic acid sequence, expression, copy number, or methylation changes using combined nuclease, ligase, polymerase, and sequencing reactions
JP7455757B2 (ja) * 2018-04-13 2024-03-26 フリーノーム・ホールディングス・インコーポレイテッド 生体試料の多検体アッセイのための機械学習実装

Also Published As

Publication number Publication date
CA3181389A1 (en) 2021-11-04
EP4143309A2 (en) 2023-03-08
EP4143309A4 (en) 2025-01-01
JP2023524016A (ja) 2023-06-08
US20230160019A1 (en) 2023-05-25
WO2021222220A3 (en) 2021-12-09
CN115812101A (zh) 2023-03-17
WO2021222220A2 (en) 2021-11-04
AU2021263680A1 (en) 2022-11-24

Similar Documents

Publication Publication Date Title
US20230160019A1 (en) Rna markers and methods for identifying colon cell proliferative disorders
CN115667554B (zh) 通过核酸甲基化分析检测结直肠癌的方法和系统
US20240084397A1 (en) Methods and systems for detecting cancer via nucleic acid methylation analysis
US20230175058A1 (en) Methods and systems for abnormality detection in the patterns of nucleic acids
JP2022521492A (ja) 相同組換え欠損を推定するための統合された機械学習フレームワーク
KR20220133868A (ko) 패치 컨볼루션 신경망을 사용한 암 분류
WO2019191649A1 (en) Methods and systems for analyzing microbiota
JP2021521536A (ja) 生体試料の多検体アッセイのための機械学習実装
US20230272486A1 (en) Tumor fraction estimation using methylation variants
US20250146081A1 (en) Tcr/bcr profiling for cell-free nucleic acid detection of cancer
AU2024210217A1 (en) Methods and systems for detecting and assessing liver conditions
HK40107669A (zh) 用於通过核酸甲基化分析检测癌症的方法和系统

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

R18-X000 Changes to party contact information recorded

St.27 status event code: A-3-3-R10-R18-oth-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

A201 Request for examination
E13-X000 Pre-grant limitation requested

St.27 status event code: A-2-3-E10-E13-lim-X000

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PA0201 Request for examination

St.27 status event code: A-1-2-D10-D11-exm-PA0201

PE0902 Notice of grounds for rejection

St.27 status event code: A-1-2-D10-D21-exm-PE0902